MENLO PARK, CA -- (MARKET WIRE) -- January 16, 2007 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced that it has received notice from the NASDAQ Staff that it has regained compliance with NASDAQ's $1.00 per share bid price requirement. This closes the matter which was raised by the staff in a November 11, 2006 letter in which the Company was notified that it was not in compliance with this listing requirement.
